Under condition I, a significant increase in the number of CD19+ B-cells compared to baseline levels in the HCs was observed, whereas in the CVID patients, B-cell numbers increased as well, but showed no significant difference compared to the ex vivo condition (Figure 2A). This evidence concerns the gene CD19 and common variable immunodeficiency.